U.S. Congestive Heart Failure Treatment Devices Market Size & Outlook
U.S. congestive heart failure treatment devices market, 2018-2030 (US$M)
Related Markets
U.S. congestive heart failure treatment devices market highlights
- The U.S. congestive heart failure treatment devices market generated a revenue of USD 2,085.9 million in 2024 and is expected to reach USD 3,039.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.5% from 2025 to 2030.
- In terms of segment, implantable cardioverter defibrillators was the largest revenue generating product in 2024.
- Counter Pulsation Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Congestive heart failure treatment devices market data book summary
| Market revenue in 2024 | USD 2,085.9 million |
| Market revenue in 2030 | USD 3,039.8 million |
| Growth rate | 6.5% (CAGR from 2025 to 2030) |
| Largest segment | Implantable cardioverter defibrillators |
| Fastest growing segment | Counter Pulsation Devices |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ventricular Assist Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy, Counter Pulsation Devices |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Abbott Laboratories, Jarvik Heart, ReliantHeart, Biotronik SE & Co., KG, Berlin Heart GmbH |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.4% of the global congestive heart failure treatment devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. congestive heart failure treatment devices market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 3,039.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Congestive Heart Failure Treatment Devices Market Scope
Congestive Heart Failure Treatment Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. congestive heart failure treatment devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to congestive heart failure treatment devices market will help companies and investors design strategic landscapes.
Implantable cardioverter defibrillators was the largest segment with a revenue share of 39.61% in 2024. Horizon Databook has segmented the U.S. congestive heart failure treatment devices market based on ventricular assist devices, implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy, counter pulsation devices covering the revenue growth of each sub-segment from 2018 to 2030.
U.S. accounts for the largest share of North America CHF treatment devices market. The market is driven by the growing prevalence of cardiovascular diseases, mainly congestive heart failure. In addition, the scenario is favorable due to the reimbursement coverage provided by the Centers of Medicare and Medicaid Services (CMS) and other private insurers. The key market players are Abbott, Boston Scientifics Corporation, Medtronic, and St. Jude Medical.
Reasons to subscribe to U.S. congestive heart failure treatment devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. congestive heart failure treatment devices market databook
-
Our clientele includes a mix of congestive heart failure treatment devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. congestive heart failure treatment devices market, including forecasts for subscribers. This country databook contains high-level insights into U.S. congestive heart failure treatment devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. congestive heart failure treatment devices market size, by product, 2018-2030 (US$M)
U.S. Congestive Heart Failure Treatment Devices Market Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
